Oncology

Vitamins and Prostate Cancer

The reduction of prostate cancer risk through the administration of vitamin C or E or selenium has been discussed, but up to now trials have not confirmed this effect by antioxidants. Now, two new investigations are available: in the first one, 35,533 males older than 50, without prostate cancer, have been treated with 200 μg of selenium a day, 400 UI of vitamin E, both products or none of them. They have been invited to undergo yearly prostate controls: about 85% of them measured yearly PSA and 70% underwent rectal exploration.
Read more

 http://mn.medsurfnews.com/contents/en/3649/display/vitamins-...

MedNews